国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Chlorobium chlorochromatii Methionyl-tRNA formyltransferase (fmt) CSB-YP662782CBAA
CSB-EP662782CBAA
CSB-BP662782CBAA
CSB-MP662782CBAA
CSB-EP662782CBAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlorobium chlorochromatii Imidazole glycerol phosphate synthase subunit HisF (hisF) CSB-YP662783CBAA
CSB-EP662783CBAA
CSB-BP662783CBAA
CSB-MP662783CBAA
CSB-EP662783CBAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlorobium chlorochromatii Elongation factor P (efp) CSB-YP662784CBAA
CSB-EP662784CBAA
CSB-BP662784CBAA
CSB-MP662784CBAA
CSB-EP662784CBAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlorobium chlorochromatii Succinyl-CoA ligase [ADP-forming] subunit beta (sucC) CSB-YP662785CBAA
CSB-EP662785CBAA
CSB-BP662785CBAA
CSB-MP662785CBAA
CSB-EP662785CBAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlorobium chlorochromatii 5'-nucleotidase surE (surE) CSB-YP662786CBAA
CSB-EP662786CBAA
CSB-BP662786CBAA
CSB-MP662786CBAA
CSB-EP662786CBAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlorobium chlorochromatii Trigger factor (tig) CSB-YP662787CBAA
CSB-EP662787CBAA
CSB-BP662787CBAA
CSB-MP662787CBAA
CSB-EP662787CBAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlorobium chlorochromatii Probable transcriptional regulatory protein Cag_0165 (Cag_0165) CSB-YP662788CBAA
CSB-EP662788CBAA
CSB-BP662788CBAA
CSB-MP662788CBAA
CSB-EP662788CBAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlorobium chlorochromatii Phosphoheptose isomerase (gmhA) CSB-YP662789CBAA
CSB-EP662789CBAA
CSB-BP662789CBAA
CSB-MP662789CBAA
CSB-EP662789CBAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. 50S ribosomal protein L10 (rplJ) CSB-YP662790SBAD
CSB-EP662790SBAD
CSB-BP662790SBAD
CSB-MP662790SBAD
CSB-EP662790SBAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Peptidyl-tRNA hydrolase (pth) CSB-YP662791SBAD
CSB-EP662791SBAD
CSB-BP662791SBAD
CSB-MP662791SBAD
CSB-EP662791SBAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. 15,16-dihydrobiliverdin:ferredoxin oxidoreductase (pebA) CSB-YP662792SBAD
CSB-EP662792SBAD
CSB-BP662792SBAD
CSB-MP662792SBAD
CSB-EP662792SBAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. 50S ribosomal protein L4 (rplD) CSB-YP662793SBAD
CSB-EP662793SBAD
CSB-BP662793SBAD
CSB-MP662793SBAD
CSB-EP662793SBAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Photosystem II reaction center protein M (psbM), partial CSB-YP662794SBAD
CSB-EP662794SBAD
CSB-BP662794SBAD
CSB-MP662794SBAD
CSB-EP662794SBAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Polyribonucleotide nucleotidyltransferase (pnp), partial CSB-YP662795SBAD
CSB-EP662795SBAD
CSB-BP662795SBAD
CSB-MP662795SBAD
CSB-EP662795SBAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Uridylate kinase (pyrH) CSB-YP662796SBAD
CSB-EP662796SBAD
CSB-BP662796SBAD
CSB-MP662796SBAD
CSB-EP662796SBAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Phenylalanine--tRNA ligase beta subunit (pheT), partial CSB-YP662797SBAD
CSB-EP662797SBAD
CSB-BP662797SBAD
CSB-MP662797SBAD
CSB-EP662797SBAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Argininosuccinate synthase (argG) CSB-YP662798SBAD
CSB-EP662798SBAD
CSB-BP662798SBAD
CSB-MP662798SBAD
CSB-EP662798SBAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Urease accessory protein UreG (ureG) CSB-YP662799SBAD
CSB-EP662799SBAD
CSB-BP662799SBAD
CSB-MP662799SBAD
CSB-EP662799SBAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. UDP-N-acetylglucosamine--N-acetylmuramyl- (pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase (murG) CSB-YP662800SBAD
CSB-EP662800SBAD
CSB-BP662800SBAD
CSB-MP662800SBAD
CSB-EP662800SBAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Heat-inducible transcription repressor HrcA (hrcA) CSB-YP662801SBAD
CSB-EP662801SBAD
CSB-BP662801SBAD
CSB-MP662801SBAD
CSB-EP662801SBAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>